|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net increase (decrease) in net assets resulting from operations | ||||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | ||||
| Amortization of deferred debt issuance costs | ||||
| Accretion of discounts and amortization of premiums on investments | ||||
| Accretion of discounts and amortization of premiums on issued debt securities | ||||
| Net realized (gain) loss on investments | ||||
| Net realized (gain) loss on foreign currency transactions | ||||
| Net realized (gain) loss on forward currency contracts | ||||
| Foreign exchange | ||||
| Total net realized (gain) loss on forward currency contracts | ||||
| Net realized (gain) loss on extinguishment of debt | ||||
| Net change in unrealized (appreciation) depreciation on investments | ||||
| Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies | ||||
| Net change in unrealized (appreciation) depreciation on derivatives | ||||
| Interest Rate Swap | ||||
| Foreign exchange | ||||
| Total net change in unrealized (appreciation) depreciation on derivatives | ||||
| Proceeds from (fundings of) revolving loans, net | ||||
| Fundings of investments | ||||
| Proceeds from principal payments and sales of portfolio investments | ||||
| Proceeds from settlements of forward currency contracts | ||||
| PIK interest | ||||
| Payment-in-kind interest capitalized | ||||
| Non-cash dividends capitalized | ||||
| Proceeds from non-cash dividends | ||||
| Cash acquired in GBDC 3 Merger | ||||
| Changes in operating assets and liabilities: | ||||
| Cash collateral held at broker for derivatives | ||||
| Interest receivable | ||||
| Receivable for investments | ||||
| Other assets | ||||
| Interest payable | ||||
| Management and income incentive fees payable | ||||
| Accrued trustee fees | ||||
| Payable for investments purchased | ||||
| Accounts payable and other liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash flows from financing activities | ||||
| Borrowings on debt | ||||
| Repayments of debt | ||||
| Capitalized debt issuance costs | ||||
| Net proceeds from issuance of common stock (Note 13) | ||||
| Purchases of common stock (Note 13) | ||||
| Distributions paid | ||||
| Purchases of common stock for dividend reinvestment plan | ||||
| Net cash provided by (used in) financing activities | ||||
| Net change in cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies | ||||
| Effect of foreign currency exchange rates | ||||
| Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, beginning of period | ||||
| Cash and cash equivalents, foreign currencies, restricted cash and cash equivalents and restricted foreign currencies, end of period | ||||
| Foreign currencies, cost | ||||
| Supplemental disclosure of cash flow information: | ||||
| Cash paid during the period for interest | ||||
| Distributions declared for the period | ||||
| Supplemental disclosure of non-cash financing activities: | ||||
| Acquisition of subsidiaries | ||||
| Stock issued in connection with dividend reinvestment plan | ||||
| Proceeds from issuance of Class A-2-R GCIC 2018 Notes | ||||
| Redemptions of Class A-2 GCIC 2018 Notes | ||||
| Noncash assets acquired: | ||||
| Investments, at cost | ||||
| Interest receivable | ||||
| Unrealized appreciation on forward currency contracts | ||||
| Receivable for investments sold | ||||
| Other assets | ||||
| Total noncash assets purchased | ||||
| Liabilities assumed: | ||||
| Debt | ||||
| Interest payable | ||||
| Distributions payable | ||||
| Management and income incentive fees payable | ||||
| Accrued trustee fees | ||||
| Accounts payable and other liabilities | ||||
| Total liabilities assumed | ||||
| Issuance of common stock | ||||
| Merger costs capitalized into purchase price | ||||
| Reconciliation of cash and cash equivalents, foreign currencies and restricted cash and cash equivalents and restricted foreign currencies | ||||
| Cash and cash equivalents | ||||
| Foreign currencies (cost of $11,685 and $7,973, respectively) | ||||
| Restricted cash and cash equivalents | ||||
| Restricted foreign currencies (cost of $0 and $1,219, respectively) | ||||
Loading...